QR code

P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease

Abstract Alzheimer’s disease (AD) is characterised by a long preclinical phase. Although phosphorylated tau (p‐tau) species such as p‐tau217 and p‐tau231 provide accurate detection of early pathological changes, other biomarkers capable of staging disease progression during preclinical AD are still...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Juan Lantero‐Rodriguez, Anniina Snellman, Andrea L Benedet, Marta Milà‐Alomà, Elena Camporesi, Laia Montoliu‐Gaya, Nicholas J Ashton, Agathe Vrillon, Thomas K Karikari, Juan Domingo Gispert, Gemma Salvadó, Mahnaz Shekari, Christina E Toomey, Tammaryn L Lashley, Henrik Zetterberg, Marc Suárez‐Calvet, Gunnar Brinkmalm, Pedro Rosa Neto, Kaj Blennow
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer Nature 2021-11-01
Reeks:EMBO Molecular Medicine
Onderwerpen:
Alzheimer’s disease
biomarkers
CSF
p‐tau235
tau
Online toegang:https://doi.org/10.15252/emmm.202115098
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items